InsiderTrades

Form 4 for GMED GLOBUS MEDICAL INC

Accepted 2021-08-03 00:00:00 ET · period of report 2021-08-02 · accession 0001209191-21-049452 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-08-03 2021-08-02 GMED Pfeil Keith W SVP, CFO M - OptEx $53.27 +833 833 New +$44.4K
D 2021-08-03 2021-08-02 GMED Pfeil Keith W SVP, CFO S - Sale+OE $83.24 -833 0 -100% -$69.3K
D 2021-08-03 2021-08-02 GMED Pfeil Keith W SVP, CFO M - OptEx $0.00 -833 24.2K -3% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2021-08-02 M A 833 $53.27 833 D — —
2 Common Class A Common Stock 2021-08-02 S D 833 $83.24 0 D — — (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.24 to $83.25, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
3 Derivative Stock Option (Right to Buy Class A Common Stock) 2021-08-02 M D 833 $0.00 24,167 D $53.27 · — to 2030-01-22 833 Class A Common Stock (F3) These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.